(MedPage Today) -- A third of randomized clinical trials in breast cancer had published results that showed bias in the reporting of endpoints, and two-thirds showed bias in reporting toxicity, authors of a literature review concluded. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment